In a market riddled with geopolitical uncertainty and the ongoing Iran War, which has led to a broader retreat from risk assets, one stock is pulling off a rare feat, having already rewarded investors with double-digit returns while appreciating as much as 85% in the last six months.
The stock in question is Acutaas Chemicals, whose shares have surged 70% in the last six months and 35% on a year-to-date basis, as the company successfully pivots from pharmaceutical intermediaries to electric vehicle energy. But what's the secret behind this successful transition? The answer is 'blood of the battery'.
Indeed, Acutaas has become the nation's first mover in lithium-ion solvents, which are essentially high-value components that form battery electrolytes.
ALSO READ: Citi Warns Of A Subdued Year Of Growth For Indian IT; Picks Two Key Favourites
There are already established players, such as Gujarat Fluorochemicals and Neogen Chemicals, that dominate the LiPF6 electrolyte segment. But Acutaas appears to have found a high-margin niche in solvents. How so? By avoiding a direct collision with backwards-integrated Chinese competitors in the electrolyte.
That means the global macro conditions are directly playing into the hands of Acutaas. An "anti-involution" policy in China has wiped out large solvent capacities, thereby raising global prices, at a time when manufacturers in Japan and South Korea look to decouple their supply chains from Beijing.
With no domestic competition in India today, Acutaas has transitioned from a pioneer to a monopoly. The execution has been evident in the numbers, with the company's Ebitda margin exploding from 16% in late 2023 to 38% in December 2025, driven by massive operating leverage.
Keeping the recent improvement in mind, the management has since upgraded its FY26 revenue guidance to 30%.
But beyond the battery boom, Actuaas is also scaling up its Contract Development and Manufacturing Organisation pipeline. With four products already validated and a revenue aspiration of Rs 1,000 crore by 2028, the company is positioning itself as a future-proof chemistry giant.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
